Across TCGA pan-cancer cohorts, GNG5P3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated GNG5P3 data layer.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher GNG5P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GNG5P3 expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.
READ, DLBC, and LUSC are the cancer types where GNG5P3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.